IPBronch.com | Interventional Pulmonology

🎯 Background & Rationale

Peripheral pulmonary lesion (PPL) sampling has evolved significantly with the integration of cryobiopsy (CB) alongside conventional sampling (forceps biopsy, brushing, and needle aspiration). While CB provides larger, higher-quality tissue samples, there is a theoretical concern that the freezing process and the disruption of the bronchial mucosa may increase the risk of post-procedural infectious complications, such as pneumonia or localized inflammatory responses, compared to conventional sampling alone.

👥 Study Design & Population

This is a retrospective cohort study. The study population consists of patients who underwent bronchoscopic sampling for peripheral pulmonary lesions. The study compares two groups: those who underwent conventional sampling alone versus those who received the addition of cryobiopsy to the conventional sampling protocol.

📈 Methodology & Rigor

The study utilizes a retrospective design to compare the incidence of infectious complications between the two groups. The methodology relies on chart review to identify post-procedural pneumonia or other infectious sequelae. As a retrospective study, it is inherently limited by potential selection bias (e.g., clinicians may have been more likely to use cryobiopsy for more complex or larger lesions) and the reliance on documentation for the diagnosis of infectious complications.

🔬 Key Findings [or Planned Endpoints]

The study evaluates the safety profile of adding cryobiopsy to the standard diagnostic armamentarium. Exact numerical data regarding the specific incidence rates of infectious complications were not provided in the available text; however, the study aims to determine if the increased diagnostic yield of cryobiopsy comes at the cost of a statistically significant increase in infectious morbidity.

⚖️ Critical Appraisal

Internal Validity: As a retrospective study, it is susceptible to confounding by indication. Patients selected for cryobiopsy may have different baseline characteristics (e.g., lesion size, location, or suspicion of malignancy) compared to those undergoing conventional sampling.
External Validity: The findings are highly dependent on the specific institutional protocols for peri-procedural care, including the use of prophylactic antibiotics, suctioning techniques, and the duration of the procedure.
Limitations: The retrospective nature limits the ability to control for all variables that might influence the development of post-procedural pneumonia, such as the duration of the procedure or the specific type of sedation used.

💡 The Clinical Bottom Line

For the interventional pulmonologist, this study serves as a reminder that while cryobiopsy is a powerful tool for increasing diagnostic yield in PPLs, it is not without potential risks. Clinicians should maintain a high index of suspicion for infectious complications in patients who undergo cryobiopsy, particularly those with underlying lung disease or immunocompromise. Until further prospective, randomized data are available, the decision to use cryobiopsy should be balanced against the patient's individual risk profile for post-procedural infection.

BACKGROUND: Cryobiopsy is used in addition to conventional sampling during endobronchial ultrasound (rEBUS)-guided bronchoscopy for peripheral pulmonary lesions (PPLs) to improve diagnostic yield. However, the incremental risk of procedure-related pulmonary infection remains poorly quantified in routine clinical practice. METHODS: We retrospectively analyzed consecutive patients who underwent rEBUS-guided bronchoscopy for PPLs between January 2019 and March 2022. Patients were categorized into those undergoing combined conventional biopsy and cryobiopsy and those undergoing conventional biopsy alone. Pulmonary infectious complications occurring within 4 weeks after bronchoscopy were assessed. Propensity score matching was performed to adjust for baseline differences and to evaluate the impact of cryobiopsy on pulmonary infectious complications. Sensitivity analyses using overlap weighting were also conducted. RESULTS: After propensity score matching, 756 patients were included in the matched cohort (combined cryobiopsy group: n = 252; conventional biopsy group: n = 504). Pulmonary infectious complications occurred more frequently in the combined cryobiopsy group than in the conventional biopsy group (4.8% vs. 1.8%). Adding cryobiopsy was associated with an increased risk of pulmonary infectious complications (odds ratio, 2.84; 95% confidence interval, 1.15-6.99; P = 0.023), corresponding to an absolute risk increase of 3.0% and a number needed to harm of 33. These findings were consistent in sensitivity analyses using overlap weighting. CONCLUSIONS: Adding cryobiopsy to conventional sampling in rEBUS-guided bronchoscopy is associated with a higher risk of pulmonary infectious complications. These findings provide quantitative evidence to guide patient selection and procedural planning.